News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoVector to Commercialize First Biologic Nanoparticle Drug Delivery System



12/2/2008 10:22:18 AM

RALEIGH, N.C.--(BUSINESS WIRE)--NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors’ Stefan Franzen and Steven Lommel from North Carolina State University. “This is breakaway technology that will finally provide the highly sought after selective targeting of tumors and intracellular delivery of anti-cancer agents for improved efficacy and fewer unpleasant side effects,” said Albert Bender, Ph.D., NanoVector CEO. “The plant virus nanoparticle has evolved over millions of years to have several inherent characteristics essential for a successful nanoparticle delivery system and superior to any chemistry based nanoparticle designed and engineered by humans.” continued Dr. Bender.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES